Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children-Reference-Cited by-同舟云学术

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

Published:2006-07-11 Issue:1 Volume:6 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Resino Salvador,Larrú Beatriz,Ma Bellón Jose,Resino Rosa,de José Ma Isabel,Navarro Marisa,Léon Juan Antonio,Ramos José Tomás,Mellado Ma José,Muñoz-Fernández Ma Ángeles

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-6-107/fulltext.html

Reference18 articles.

1. de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P: Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000, 284: 190-197. 10.1001/jama.284.2.190.

2. Resino S, Bellón JM, Resino R, Navarro ML, Ramos JT, Mellado MJ, de Jose MI, Muñoz-Fernández MA: Extensive implementation of highly active antiretroviral therapy shows great effectiveness on the survival and surrogate markers in vertically HIV-infected children. Clin Infect Dis. 2004, 38: 1605-1612. 10.1086/420738.

3. Krogstad P, Lee S, Johnson G, Stanley K, McNamara J, Moye J, Jackson JB, Aguayo R, Dieudonne A, Khoury M, Mendez H, Nachman S, Wiznia A: Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Clin Infect Dis. 2002, 34: 991-1001. 10.1086/338814.

4. Nadal D, Steiner F, Cheseaux JJ, Lazarevitch CA, Aebi C, Kind C, Rudin C: Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland. Infection. 2000, 28: 287-296. 10.1007/s150100070021.

5. Gatti G, Castelli-Gattinara G, Cruciani M, Bernardi S, De Pascalis CR, Pontali E, Papa L, Miletich F, Bassetti D: Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2003, 36: 1476-1482. 10.1086/375062.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective strategies for neonatal hypoxic-ischemic brain damage: Current status and challenges;European Journal of Pharmacology;2023-10

2. Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review;HIV Medicine;2019-04-22

3. New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013;Medicine;2017-09

4. If you build it, will they come? A qualitative investigation into community barriers to accessing paediatric HIV services in Kenya;Children and Youth Services Review;2014-10

5. Leitlinie der Pädiatrische Arbeitsgemeinschaft AIDS (PAAD) e.V. zur antiretroviralen Therapie bei HIV-infizierten Kindern und Jugendlichen (2011);Klinische Pädiatrie;2012-03